IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ROMANI, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.886
EU - Europa 2.209
AS - Asia 2.179
SA - Sud America 334
AF - Africa 51
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 9.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.781
SG - Singapore 762
CN - Cina 667
PL - Polonia 617
IT - Italia 400
BR - Brasile 276
DE - Germania 266
UA - Ucraina 250
HK - Hong Kong 233
VN - Vietnam 167
FI - Finlandia 159
GB - Regno Unito 114
FR - Francia 103
TR - Turchia 79
IE - Irlanda 64
IN - India 64
CA - Canada 61
RU - Federazione Russa 61
BD - Bangladesh 42
NL - Olanda 36
ID - Indonesia 33
SE - Svezia 29
AR - Argentina 28
MX - Messico 28
ZA - Sudafrica 24
EE - Estonia 23
IQ - Iraq 23
ES - Italia 19
JP - Giappone 19
AT - Austria 11
CZ - Repubblica Ceca 11
PK - Pakistan 11
BE - Belgio 10
LT - Lituania 9
AU - Australia 8
KG - Kirghizistan 8
EC - Ecuador 7
BG - Bulgaria 6
CO - Colombia 6
KR - Corea 6
NP - Nepal 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
LK - Sri Lanka 5
MA - Marocco 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
EG - Egitto 4
IL - Israele 4
JO - Giordania 4
KZ - Kazakistan 4
MY - Malesia 4
NG - Nigeria 4
NI - Nicaragua 4
PH - Filippine 4
PY - Paraguay 4
UZ - Uzbekistan 4
CR - Costa Rica 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
KE - Kenya 3
PT - Portogallo 3
VE - Venezuela 3
AL - Albania 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LY - Libia 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
Totale 9.672
Salva come PNG Salva come JPEG
Città #
Warsaw 612
Ashburn 514
Fairfield 466
Singapore 450
Woodbridge 328
Houston 282
San Jose 253
Chandler 241
Seattle 219
Hong Kong 212
New York 179
Jacksonville 175
Wilmington 165
Cambridge 143
Beijing 142
The Dalles 141
Ann Arbor 128
Los Angeles 121
Dearborn 106
Helsinki 104
Princeton 101
Brescia 95
Dublin 64
Nanjing 63
Council Bluffs 61
Istanbul 59
Munich 59
Lauterbourg 55
Dallas 50
Milan 48
Shanghai 45
Dong Ket 44
Ho Chi Minh City 39
São Paulo 37
Buffalo 33
London 33
Chicago 31
Des Moines 31
Hanoi 31
Moscow 29
San Francisco 29
Toronto 26
Orem 24
Jakarta 23
Tallinn 23
Denver 21
San Diego 21
Redondo Beach 20
Shenyang 20
Tianjin 20
Jinan 19
Johannesburg 19
Turku 19
Chennai 18
Montreal 18
Nanchang 18
Santa Clara 18
Tokyo 17
Brooklyn 16
Kunming 15
Phoenix 15
Central 14
Changsha 14
Hangzhou 14
Nuremberg 14
Rome 14
Hebei 13
Poplar 13
Guangzhou 12
Jiaxing 12
Stockholm 12
Paris 11
Zhengzhou 11
Atlanta 10
Boston 10
Charlotte 10
Manchester 10
Mexico City 10
Monmouth Junction 10
Kyiv 9
Amsterdam 8
Ankara 8
Belo Horizonte 8
Bishkek 8
Lappeenranta 8
Mumbai 8
Brussels 7
Falkenstein 7
Haiphong 7
Leawood 7
Miami 7
Norwalk 7
Rio de Janeiro 7
Vancouver 7
Verona 7
Baghdad 6
Boardman 6
Curitiba 6
Da Nang 6
Frankfurt am Main 6
Totale 6.772
Salva come PNG Salva come JPEG
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 355
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 351
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 328
Claudin3 is localized outside the tight junctions in human carcinomas 290
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 285
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 221
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 219
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 207
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 206
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 200
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 198
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 198
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 197
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 190
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 187
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 185
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 181
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 177
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 176
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. 172
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 172
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 172
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 169
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 168
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 168
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 166
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 164
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 160
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 152
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 147
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 142
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 136
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 136
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 135
Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R. 131
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 128
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 128
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 124
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 123
Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables 121
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response. 117
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 115
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 114
OVEREXPRESSION OF EPIDERMAL GROWTH FACTOR TYPE-1 RECEPTOR (EGF-R1) IN CERVICAL CANCER: IMPLICATIONS FOR CETUXIMAB-MEDIATED THERAPY IN RECURRENT/METASTATIC DISEASE. 114
Integrated mutational landscape analysis of uterine leiomyosarcomas 112
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 111
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 111
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 110
HE4 and epithelial ovarian cancer : Comparison and clinical evaluation of two immunoassays and a combination algorithm 105
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 103
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 102
Human papillomavirus type 16 (HPV-16) virus-like particleL1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. 100
Trop-2 Overexpression in Poorly Differentiated Endometrial Endometrioid Carcinoma: Implications for Immunotherapy With hRS7, a Humanized Anti-Trop-2 Monoclonal Antibody 94
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 91
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer 89
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 83
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 83
The VEGF/VEGFR2 system in ovarian cancer: From functional to pharmacological significance 78
Finding the junction between claudins and endometrial carcinoma 77
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 77
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 70
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies 69
The prognostic role of salivary miRNAs in oral squamous cell carcinoma: technical challenges and clinical perspectives 59
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 51
Mammaglobin B (SCGB2A1) is a novel tumor antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy 43
HPV16VLP L1-Specific CD8+ cytotoxic T lymphocytes (CTL) are equally effective as E7-specific CD8+ CTL in killing autologous HPV16 positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines 40
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders 32
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling 15
Totale 9.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.449
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021293 0 0 0 0 0 0 0 0 0 135 86 72
2021/2022544 64 92 11 3 5 32 48 28 26 97 38 100
2022/2023611 90 38 32 40 60 126 8 66 84 6 35 26
2023/2024775 38 25 78 56 43 189 45 45 124 44 15 73
2024/20251.425 28 41 29 246 112 148 109 51 137 94 265 165
2025/20263.044 310 273 213 472 391 263 562 134 207 219 0 0
Totale 9.830